# Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)

> **NCT03183609** · NA · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 40 (actual)

## Conditions studied

- Schizophrenia
- Gluten Sensitivity
- Schizo Affective Disorder

## Interventions

- **OTHER:** Gluten Flour in Protein Shake
- **OTHER:** Rice Flour in Protein Shake

## Key facts

- **NCT ID:** NCT03183609
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-10
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-03-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183609, "Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03183609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*